|
Volumn 32, Issue 4, 2014, Pages 331-333
|
Does CRISPR-Cas open new possibilities for patents or present a moral maze?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CRISPR ASSOCIATED PROTEIN;
AMINO ACID SEQUENCE;
ARTICLE;
BACTERIAL GENOME;
CARCINOGENIC ACTIVITY;
CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT;
CRISPR CAS SYSTEM;
DNA SEQUENCE;
GENE SEQUENCE;
GOVERNMENT;
HUMAN;
INDEL MUTATION;
MICROORGANISM;
MORALITY;
NONHUMAN;
PATENT;
PRIORITY JOURNAL;
TRANSGENIC ANIMAL;
TRANSGENIC PLANT;
ANIMAL;
BIOTECHNOLOGY;
ETHICS;
LEGISLATION AND JURISPRUDENCE;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
BIOTECHNOLOGY;
CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS;
CRISPR-CAS SYSTEMS;
PATENTS AS TOPIC;
|
EID: 84900854113
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2843 Document Type: Article |
Times cited : (13)
|
References (13)
|